Danske Bank A S Purchases Shares of 98,694 The Cooper Companies, Inc. $COO

Danske Bank A S purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 2nd quarter, HoldingsChannel reports. The fund purchased 98,694 shares of the medical device company’s stock, valued at approximately $7,077,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. BlackRock Inc. bought a new position in Cooper Companies during the second quarter valued at about $1,077,762,000. State Street Corp grew its holdings in Cooper Companies by 2.4% during the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock worth $720,736,000 after acquiring an additional 207,195 shares during the period. Wellington Management Group LLP raised its position in Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after acquiring an additional 4,756,178 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after acquiring an additional 2,231,568 shares in the last quarter. Finally, Sustainable Growth Advisers LP lifted its holdings in Cooper Companies by 22.1% in the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after acquiring an additional 747,476 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Needham & Company LLC reduced their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Citigroup reiterated a “neutral” rating and issued a $80.00 target price (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. UBS Group assumed coverage on shares of Cooper Companies in a report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 target price for the company. Finally, Robert W. Baird decreased their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $81.64.

Cooper Companies Stock Performance

Shares of COO opened at $76.22 on Friday. The company has a market capitalization of $14.87 billion, a PE ratio of 64.59, a PEG ratio of 1.99 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The company’s 50 day moving average price is $71.93 and its 200 day moving average price is $71.16. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.